|
SCAI expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.49009999970285E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.57190000002772E-06 |
| Normal-vs-Stage2 |
3.804200E-01 |
| Normal-vs-Stage3 |
5.80120000037709E-07 |
| Normal-vs-Stage4 |
6.09090000658341E-10 |
| Stage1-vs-Stage2 |
1.212430E-01 |
| Stage1-vs-Stage3 |
5.877700E-02 |
| Stage1-vs-Stage4 |
4.247500E-04 |
| Stage2-vs-Stage3 |
2.190100E-02 |
| Stage2-vs-Stage4 |
3.580800E-03 |
| Stage3-vs-Stage4 |
2.575000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.46429999994913E-06 |
| Normal-vs-AfricanAmerican |
4.29760000000279E-05 |
| Normal-vs-Asian |
1.807040E-01 |
| Caucasian-vs-AfricanAmerican |
6.554400E-01 |
| Caucasian-vs-Asian |
7.113200E-01 |
| AfricanAmerican-vs-Asian |
5.239000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.25639999959404E-07 |
| Normal-vs-Female |
4.576900E-04 |
| Male-vs-Female |
5.106200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.156050E-04 |
| Normal-vs-Age(41-60Yrs) |
2.445700E-04 |
| Normal-vs-Age(61-80Yrs) |
1.81530000031849E-07 |
| Normal-vs-Age(81-100Yrs) |
1.126450E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.918100E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.626200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.403200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.013820E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.913400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.669800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.837000E-01 |
| Normal-vs-Grade 2 |
1.843740E-03 |
| Normal-vs-Grade 3 |
1.17370000385364E-08 |
| Normal-vs-Grade 4 |
7.03914704303088E-12 |
| Grade 1-vs-Grade 2 |
8.325600E-02 |
| Grade 1-vs-Grade 3 |
8.655300E-03 |
| Grade 1-vs-Grade 4 |
2.5892999999666E-06 |
| Grade 2-vs-Grade 3 |
4.235200E-03 |
| Grade 2-vs-Grade 4 |
8.25279999894235E-08 |
| Grade 3-vs-Grade 4 |
2.463700E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.163900E-03 |
| Normal-vs-ccB subtype |
4.08899999970735E-07 |
| ccA subtype-vs-ccB subtype |
1.444200E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.838400E-04 |
| Normal-vs-N1 |
4.09290001890383E-09 |
| N0-vs-N1 |
1.815160E-04 |
|
|
